Highly active antiretroviral treatment (HAART) was given early to 64 patients with
symptomatic primary human immunodeficiency virus (HIV)-1 infection. At the time of …

We compared clinical disease progression in 159 human immunodeficiency virus (HIV)-
infected persons for whom highly active antiretroviral therapy (HAART) was initiated when …

Background Short-course antiretroviral therapy (ART) in primary human immunodeficiency
virus (HIV) infection may delay disease progression but has not been adequately evaluated …

Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …

Highly active antiretroviral therapy (HAART) refers to a broad category of treatment regimens
usually comprised of three or more antiretroviral drugs that, in previously untreated HIV-1 …

The choice of initial antiretroviral regimen for treating people infected with HIV is crucial to
successful long-term control of virus replication. Potent antiretroviral therapy substantially …

When antiretroviral therapy first became available, it was hypothesized that the modest
clinical benefits seen in patients with advanced disease [1] would be more pronounced in …

On the basis of studies with relatively short follow-up, treatment guidelines currently
recommend that highly active antiretroviral therapy (HAART) be initiated in asymptomatic …

The treatment of HIV-infected patients has changed remarkably since early 1996 when more
potent agents became available and were used in combination therapy. Both clinical and …

Background. Whether asymptomatic human immunodeficiency virus (HIV)–infected patients
can interrupt treatment remains unknown. Methods. We performed a prospective …